Metformin intake associates with better cognitive function in patients with Huntington's disease.
Huntington's disease (HD) is an inherited, dominant neurodegenerative disorder caused by an abnormal expansion of CAG triplets in the huntingtin gene (htt). Despite extensive efforts to modify the progression of HD thus far only symptomatic treatment is available. Recent work suggests that trea...
Main Authors: | David Hervás, Victoria Fornés-Ferrer, Ana Pilar Gómez-Escribano, María Dolores Sequedo, Carmen Peiró, José María Millán, Rafael P Vázquez-Manrique |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5478119?pdf=render |
Similar Items
-
Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington disease
by: Ana Sanchis, et al.
Published: (2019-06-01) -
Reactive Species in Huntington Disease: Are They Really the Radicals You Want to Catch?
by: José Bono-Yagüe, et al.
Published: (2020-07-01) -
Metformin reverses early cortical network dysfunction and behavior changes in Huntington’s disease
by: Isabelle Arnoux, et al.
Published: (2018-09-01) -
Dietary Intake, Mediterranean Diet Adherence and Caloric Intake in Huntington’s Disease: A Review
by: Christiana C. Christodoulou, et al.
Published: (2020-09-01) -
Association between caffeine intake and age at onset in Huntington's disease
by: Clémence Simonin, et al.
Published: (2013-10-01)